K. M. Nowak
1,2, C. Girardi
2, A. Miltner
2, A. Schäffer
1, M. Kästner
2Biotransformation of ibuprofen in soil:
a new insight into non-extractable residue formation
1 Dept. Environmental Biology and Chemodynamics, Institute for Environmental Research, RWTH Aachen University, Germany
2Dept. Environmental Biotechnology, UFZ - Helmholtz Centre for Environmental Research, Leipzig, Germany
INTRODUCTION EXPERIMENTAL RESULTS CONCLUSIONS PLANS…
INTRODUCTION
MASS BALANCE OF A XENOBIOTIC IN SOIL
Microbial biomass
Incorporation
CO
2Xenobiotic
compound
Xenobiotic metabolites
SOM NER
NER structure??
Risk??
Simple systems!
Soils: mostly quantification!
1. Sequestered NER
Clay particle xenobiotic
xenobiotic binding
2. Chemically bound
INTRODUCTION EXPERIMENTAL RESULTS CONCLUSIONS PLANS…
INTRODUCTION
BioNER FROM A XENOBIOTIC IN SOIL
Incorporation
CO
2Microbial biomass Xenobiotic
compound
Xenobiotic metabolites
SOM NER
BioNER pathways?
Biomass residues
Fixation
Starvation
SOM
NER
Page 4
INTRODUCTION RESULTS CONCLUSIONS PLANS…
INTRODUCTION
IBUPROFEN (IBU)
EXPERIMENTAL
Anti-inflammatory and analgesic drug
Most commonly consumed drug
Detected in effluents and sewage sludge
Biodegraded in soil
High NER content NER structure?? Risk??
13
C
6-Ibuprofen
M
w- 206.28 g/mol
H
2O solubility - 21 mg/L
log K
ow- 3.5
INTRODUCTION RESULTS CONCLUSIONS PLANS…
INTRODUCTION
13 C 6 -IBU EXPERIMENT
EXPERIMENTAL
• Living biomass:
(PLFA and bioAA)
• Total in soil:
(non-living + living biomass:
tFA and tAA)
BioNER analysesExtractable compound residues (parent compound +
primary metabolites)
Non-extractable residues (NER) (EA-C-IRMS)
GC/MS;
GC-C-IRMS
13
C
6-IBU RESIDUES
• Darkness, 20ºC; 60% of WHC
• 13C6-IBU: 20 mg/kg
• 2, 4, 14, 28, 59 and 90 days
• 21% clay, 68% silt, 11% sand
• Abiotic, 13C-abundance controls
Labelled IBU
H2O Safety NaOH traps
trap pump
CO
2(TIC;
GC-C-IRMS)
Page 6
INTRODUCTION CONCLUSIONS PLANS…
INTRODUCTION
C-MASS BALANCE ( C 6 -IBU)
EXPERIMENTAL RESULTS
incubation time (days)
0 20 40 60 80
% of applied 13 C (from ring-labeled ibuprofen) 0 20 40 60 80 100
mineralization extractable
ibuprofen and metabolites
non-extractable residues
extractable,
unknown composition
BIOTIC ABIOTIC
incubation time (days)
0 20 40 60 80
% of applied 13 C 6 ibuprofen 0 20 40 60 80 100
proteins mineralisation
extractable ibuprofen and metabolites
NER extractable,
unknown composition
• Mineralisation: high
• NER: high → bioNER?
•
13C-IBU + metabolites:↓
• Mineralisation: low
• NER: low → time dependant
•
13C-IBU + metabolites: high NER = microbial activity!
Nowak et al, 2013 Nowak et al, 2013
INTRODUCTION CONCLUSIONS PLANS…
INTRODUCTION
INCORPORATION OF 13 C INTO FA and AA
EXPERIMENTAL RESULTS
• PLFA: fast
• PLFA:↓
incubation time (days)
0 10 20 30 40 50 60 70 80 90
13 C in FA fraction (% of initial 13 C 6-IBU equivalents) 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4
1.6 tFA
PLFA
FATTY ACIDS
Nowak et al, 2013
• bioAA: fast
• bioAA:↓
• tAA: 27%!
incubation time (days)
0 10 20 30 40 50 60 70 80 90
13 C in AA fraction (% of initial 13 C 6-IBU equivalents) 0 5 10 15 20 25 30
35 tAA
corrected biomass AA biomass AA
AMINO ACIDS
Nowak et al, 2013
• G
־markers: initial degraders
• G
+markers: later phase
• Starvation marker:↑over time
INTRODUCTION CONCLUSIONS PLANS…
INTRODUCTION
C INCORPORATION INTO BIOMASS
EXPERIMENTAL RESULTS
incubation time (days)
0 10 20 30 40 50 60 70 80 90
13 C-PLFA (% of initial 13 C 6-ibuprofen)
0.0 0.2 0.4 0.6 0.8 1.0
normal
methyl branched monounsaturated polyunsaturated cyclopropyl
PLFA
• Aspartate: initially → CO
2fixation
• diverse bioAA: later phase
incubation time (days)
0 10 20 30 40 50 60 70 80 90
13 C-bioAA (% of initial 13 C 6-IBU equivalents) 0 1 2 3 4
ala gly thr val
-ala leu ile pro asp glu phe lys
bioAA
Nowak et al, 2013 Nowak et al, 2013
INTRODUCTION CONCLUSIONS PLANS…
INTRODUCTION
CALCULATION OF TOTAL BioNER
EXPERIMENTAL RESULTS
Incorporation of
13C into the biomass of C. necator grown on
13C
6-2,4-D
tFA instable (Nowak et al, 2011)! THUS tAA → calculation
Conversion factor of ~ 2 for tAA (proteins) Name Incubation time (days) [% of
13C
6-2,4-D]
2 3 7 14
Biomass 9.2 ( ± 1.5) 10.0 ( ± 1.5) 14.5 ( ± 1.8) 17.4 ( ± 0.06) PLFA 0.5 ( ± 0.02) 0.6 ( ± 0.01) 0.8 ( ± 0.05) 0.6 ( ± 0.04) bioAA 4.7 ( ± 0.2) 6.1 ( ± 0.3) 7.3 ( ± 0.2) 8.1 ( ± 0.4)
Biomass/PLFA 18.4 17 18 29
Biomass/AA 1.9 1.6 2 2.1
13C6-2,4-D Cupriavidus necator JMP 134
GC/MS;
EA-C-IRMS GC-C-IRMS
• 13
C in PLFA and bioAA
• Total 13
C in biomass
Nowak et al, 2011
INTRODUCTION CONCLUSIONS PLANS…
INTRODUCTION
C-MASS BALANCE ( C 6 -IBU)
EXPERIMENTAL RESULTS
General mass balance New mass balance incl. BioNER
incubation time (days)
0 20 40 60 80
% of applied 13 C (from ring-labeled ibuprofen) 0 20 40 60 80 100
mineralization extractable
ibuprofen and metabolites
non-extractable residues
extractable,
unknown composition
incubation time (days)
0 20 40 60 80
% of applied 13 C (from ring-labeled ibuprofen) 0 20 40 60 80 100
proteins biogenic residues
mineralization extractable
ibuprofen and metabolites
non-extractable residues
extractable, unknown composition
Nearly all NER biogenic!
• extractable (unknown composition): bioNER?
Nowak et al, 2013 Nowak et al, 2013
INTRODUCTION EXPERIMENTAL RESULTS CONCLUSIONS PLANS…
INTRODUCTION
BioNER FROM CO 2 FIXATION
Incorporation
CO
2Microbial biomass Xenobiotic
compound
Xenobiotic metabolites
SOM NER
BioNER pathways?
Biomass residues
Fixation
Starvation
SOM
NER
INTRODUCTION RESULTS CONCLUSIONS PLANS…
INTRODUCTION
CO 2 FIXATION EXPERIMENT
EXPERIMENTAL
• Living biomass:
(PLFA)
BIONER analysesGC/MS;
GC-C-IRMS
13
C-LABEL ANALYSES
CO2 CO2
CO2
HCL
Na2CO3 Unlabelled 2,4-D
(20 mg/kg) H2O
Labelled 2,4-D Safety NaOH traps trap
pump
13
CO
2experiment
13C
6-2,4-D experiment
INCUBATION
•
13CO
2fixation (day 16)
• PLFA: decline
INTRODUCTION CONCLUSIONS PLANS…
INTRODUCTION
INCORPORATION OF 13 C INTO PLFA
EXPERIMENTAL RESULTS
incubation time (days)
0 10 20 30 40 50 60
13 C-label distribution in soil (%)
0.0 0.1 0.2 0.3 0.4 0.5 0.6
13CO2 fixation
13C6-2,4-D 13
C-incorporation into PLFA
(
13C
6-2,4-D and
13CO
2experiments)
incubation time (days)
0 10 20 30 40 50 60
% of applied 13 C (from ring-labeled 2,4-D) 0 20 40 60 80 100
mineralization
extractable, 2,4-D and meta- bolites
non-extractable residues extractable,
unknown composition
13
C-mass balance in
13C
6-2,4-D experiment
Nowak et al, 2011
Nowak et al, 2011
INTRODUCTION CONCLUSIONS PLANS…
INTRODUCTION
C IN PLFA CLASSES
EXPERIMENTAL RESULTS
• G
-markers: initially
incubation time (days)
0 10 20 30 40 50 60
13 C-PLFA (% of initial 13 CO2)
0.0 0.1 0.2 0.3
0.4 normal
methyl branched monounsaturated polyunsaturated cyclopropyl
incubation time (days)
0 10 20 30 40 50 60
13 C-PLFA (% of initial 13 C 6-2,4-D)
0.0 0.1 0.2 0.3 0.4 0.5 0.6
normal
methyl branched monounsaturated polyunsaturated cyclopropyl 13
CO
2experiment
13C
6-2,4-D experiment
• G
+markers: initially
Nowak et al, 2011 Nowak et al, 2011
INTRODUCTION PLANS…
INTRODUCTION
FINAL REMARKS
EXPERIMENTAL RESULTS CONCLUSIONS
NER from
13C
6-IBU biogenic = no risk!
NER in abiotic soil low
tAA high
bioNER from xenobiotic and CO
2HOWEVER:
no biodegradation → xenobiotic NER
bioNER → biodegradation (↑CO
2) → SOM formation
INTRODUCTION PLANS…
INTRODUCTION
SOM FORMATION
EXPERIMENTAL RESULTS CONCLUSIONS
Decay
Cell wall fragments
Cell wall fragments formation cycle
Growth
Plant
material Patchy fragments on
mineral surfaces
SOM
Starvation
Xenobiotic compound
Miltner et al, 2012
INTRODUCTION PLANS…
INTRODUCTION
FINAL REMARKS
EXPERIMENTAL RESULTS CONCLUSIONS
AND:
Biotic vs abiotic NER formations (3 types of NER)!
NER from
13C
6-IBU biogenic = no risk!
NER in abiotic soil low
tAA high
bioNER from xenobiotic and CO
2HOWEVER:
no biodegradation → xenobiotic NER
bioNER → biodegradation (↑CO
2) → SOM formation
INTRODUCTION PLANS…
INTRODUCTION
NER CLASSIFICATION
EXPERIMENTAL RESULTS CONCLUSIONS
type I: sequestered NER:
- reversible
- remobilisation → risk for the environment
Clay particle
type III: bioNER
- biomolecules (amino acids, fatty acids) → SOM - no risk
type II: chemically bound (covalent bonding)
- irreversible
- low risk for environment
xenobiotic bindingBIOTIC AND ABIOTIC NER FORMATION
INTRODUCTION PLANS…
INTRODUCTION
ABIOTIC vs BIOTIC NER FORMATION
EXPERIMENTAL RESULTS CONCLUSIONS
ABIOTIC
Covalent binding entrapment
RISK
SOM xenobiotic NER
(type I and II) Xenobiotic
compound
Xenobiotic metabolites
Incorporation
Living biomass
Starvation
Biomass residues
Stabilisation
BIOTIC
CO
2Fixation
=
SOM BioNER (type III)
low
high no
Kästner et al, in press
BioNER from other contaminants
(different structure, slower degradation)
AA: 50%, FA: 5% of BioNER: other components?
New risk assessment including bioNER formation
INTRODUCTION INTRODUCTION
FURTHER RESEARCH
EXPERIMENTAL RESULTS CONCLUSIONS PLANS…
THANK YOU FOR
YOUR ATTENTION!
EXTRACTION OF BIONER
• Total in soil:
(non-living + living biomass:
tFA and tAA)
FATTY ACIDS AMINO ACIDS
• Living biomass:
(PLFA)
• Living biomass:
(bioAA)
Purification: silica gel PLFA (CH3Cl, ACN, MeOH)
• Total in soil:
(non-living + living biomass:
tFA and tAA)
• Phospholipids (PLFA)
• Neutral lipids
• Glycolipids
Extraction:
PB/MeOH/CH3Cl (0.8/2/1, v:v)
Derivatization:
MeOH/TMCS; 9:1, v:v
GC/MS;
GC-C-IRMS Derivatization:
(MeOH/TMCS; 9:1, v:v )
Purification: silica gel (diethyl ether)
Biomass extraction:
chelating cation exchange resin+
sodium deoxycholate/Polyethylenglycol 600 (0.1%/2.5%)
Hydrolysis: 6M HCl, 110ºC
Purification: DOWEX 50W-X8 (oxalic acid, 0.01M HCl, H2O, 2.5M NH4OH)
Derivatization:
(Isopropanol/acetylchloride;
DCM/Trifluoroacetic acid anhydride)
Purification:
(PB:CH3Cl)